Cell Signaling Technology (United States)
Cell Signaling Technology, Inc. is a privately held company that develops and produces antibodies, ELISA kits, ChIP kits, proteomic kits, and other related reagents used to study the cell signaling pathways that impact human health. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Cell Signaling Technology (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
72%
Total
Publications
519
Total Open
Publications
374
Total
Citations
67K
Open Access
Percentage
72%
Total
Publications
519
Total Open
Publications
374
Total
Citations
67K
Breakdown
Publisher Open
13%
Both
36%
Other Platform Open
23%
Closed
28%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 25%
64
Hybrid 50%
128
No Guarantees 25%
65
Other Platform Open
Domain 88%
270
Institution 12%
38
Preprint 11%
33
Public 10%
31
Other Internet 9%
28
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 269 |
Europe PMC | Domain | 191 |
Figshare | Public | 43 |
bioRxiv | Preprint | 27 |
DOI | Other Internet | 24 |
Semantic Scholar | Public | 16 |
Harvard University - Digital Access to Scholarship at Harvard (DASH) | Institution | 8 |
California Digital Library - eScholarship | Other Internet | 8 |
Massachusetts Institute of Technology - DSpace@MIT | Institution | 6 |
Research Square | Preprint | 4 |